Tag Archives: Abbott

Patents on “reinvented” medications lead to higher insurance premiums

This Friday’s Wall Street Journal (June 22,2012) features an article authored by Jonathan D. Rockoff reporting that Abbott Laboratories is contesting a portion of the healthcare law regarding patent protection. Patent protections for the drug industry have a long history. … Continue reading

Posted in Politics | Tagged , , , , , , | 4 Comments